Magnesium in Breast Cancer: What Is Its Influence on the Progression of This Disease?
- 280 Downloads
Breast cancer is a disease of high mortality, characterized by the progressive accumulation of mutations that contribute to the uncontrolled development of breast tissue cells. Literature shows that disturbances in mineral homeostasis, such as magnesium, may interfere with tumor progression. The objective of this study is to provide updated information about magnesium’s role in the pathogenesis of breast cancer. A review of literature was carried out from a search for articles in the PubMed and CAPES Periodicals databases published between 1995 and 2016 with the cross-references of the descriptors “magnesium,” “breast neoplasms,” and “oxidative stress” and the corresponding words in Portuguese. We included studies on the metabolism and bioavailability of magnesium and studies related to breast cancer and excluded articles in which only the abstract was available, dissertations, theses, articles involving adjuvant and/or neoadjuvant therapies, and supplementation of minerals in breast cancer patients. Magnesium is a mineral that participates in the metabolism of various nutrients and nucleic acids. In the presence of breast cancer, neoplastic cells increase the expression of magnesium transport channels, which raises the intracellular concentration of the mineral, contributing to tumor growth through its function of increasing energy demand. The data obtained in this review illustrates the influence of magnesium on the progression of breast cancer. However, the existing data are scarce and inconsistent, which demonstrates a need for further studies on the subject with a goal to have better control of the disease.
KeywordsMagnesium Breast cancer Breast neoplasms
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
- 1.Pavithra V, Sathisha TG, Kasturi K, Mallika DS, Amos SJ, Ragunatha S (2015) Serum levels of metal ions in female patients with breast cancer. J Clin Diagn Res 9(1):25–27Google Scholar
- 16.Kolte D, Vijayaraghavan K, Khera S, Sica DA, Frishman WH (2014) Role of magnesium in cardiovascular diseases. Cardiol Rev 22(4):182–189Google Scholar
- 17.Elin RJ (2010) Assessment of magnesium status for diagnosis and therapy. Magnes Res 23(4):194–198Google Scholar
- 20.Rocha VS (2009) Avaliação bioquímica e do consumo alimentar de magnésio em mulheres saudáveis no terceiro trimestre gestacional. 2009. 97 f. Dissertação (Pós-graduação em Ciência dos Alimentos) – Faculdade de Ciências Farmacêuticas, Universidade de São Paulo, São PauloGoogle Scholar
- 22.Severo JS, Morais JBS, Freitas TEC, Cruz KJC, Oliveira ARS, Poltronieri F et al (2015) Aspectos Metabólicos e Nutricionais do Magnésio. Nutr Clín Diet Hosp 35(2):67–74Google Scholar
- 23.Institute of Medicine, Food and Nutrition Board (1997) Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D and fluoride. National Academy Press, Washington, DCGoogle Scholar
- 25.Naithani M, Bharadwaj J, Darbari A (2014) Magnesium: the fifth electrolyte. J Med Nutr Nutraceut 3(2):66–72Google Scholar
- 31.Guilbert A, Gautier M, Dhennin-Duthille I, Haren N, Sevestre H, Ouadid-Ahidouch H Evidence that TRPM7 is required for breast cancer cell proliferation. Am J Phys Cell Phys 297(3):493–502Google Scholar
- 32.Middelbeek J, Kuipers AJ, Henneman L, Visser D, Eidhof I, van Horssen R, Wieringa B, Canisius SV, Zwart W, Wessels LF, Sweep FCGJ, Bult P, Span PN, van Leeuwen FN, Jalink K (2012) TRPM7 is required for breast tumor cell metastasis. Cancer Res 72(16):4250–4261. https://doi.org/10.1158/0008-5472.CAN-11-3863 CrossRefPubMedGoogle Scholar
- 33.Guilbert A, Gautier M, Dhennin-Duthille I, Rybarczyk P, Sahni J, Sevestre H, Scharenberg AM, Ouadid-Ahidouch H (2013) Transient receptor potential melastatin 7 is involved in oestrogen receptor-negative metastatic breast cancer cells migration through its kinase domain. Eur J Cancer 49(17):3694–3707. https://doi.org/10.1016/j.ejca.2013.07.008 CrossRefPubMedGoogle Scholar
- 35.Hardy S, Uetani N, Wong N, Kostantin E, Labbé DP, Bégin LR, Mes-Masson A, Miranda-Saavedra D, Tremblay ML (2015) The protein tyrosine phosphatase PRL-2 interacts with the magnesium transporter CNNM3 to promote oncogenesis. Oncogene 34(8):986–995. https://doi.org/10.1038/onc.2014.33 CrossRefPubMedGoogle Scholar
- 36.Kostantin E, Hardy S, Valinsky WC, Kompatscher A, de Baaij JH, Zolotarov Y et al (2016) Inhibition of PRL-2·CNNM3 protein complex formation decreases breast cancer proliferation and tumor growth. J Biol Chem 291(20):10716–10725. https://doi.org/10.1074/jbc.M115.705863 CrossRefPubMedPubMedCentralGoogle Scholar
- 37.Castiglioni S, Maier JA (2011) Magnesium and cancer: a dangerous liason. Magnes Res 24(3):92–100Google Scholar
- 39.De La Cruz-Morcillo MA, García-Cano J, Arias-González L, García-Gil E et al (2013) Abrogation of the p38 MAPK α signaling pathway does not promote radioresistance but its activity is required for 5-fluorouracil-associated radiosensitivity. Cancer Lett 335(1):66–74. https://doi.org/10.1016/j.canlet.2013.01.050 CrossRefPubMedGoogle Scholar
- 45.Mirmalek SA, Jangholi E, Jafari M, Yadollah-Damavandi S, Javidi MA, Parsa Y, Parsa T, Salimi-Tabatabaee SA, Kolagar HG, Jalil SK, Alizadeh-Navaei R (2016) Comparison of in vitro cytotoxicity and apoptogenic activity of magnesium chloride and cisplatin as conventional chemotherapeutic agents in the MCF-7 cell line. Asian Pac J Cancer Prev 17(S3):131–134. https://doi.org/10.7314/APJCP.2016.17.S3.131 CrossRefPubMedGoogle Scholar
- 46.Tao MH, Dai Q, Millen AE, Nie J, Edge SB, Trevisan M, Shields PG, Freudenheim JL (2015) Associations of intakes of magnesium and calcium and survival among women with breast cancer: results from Western New York Exposures and Breast Cancer (WEB) Study. Am J Cancer Res 6(1):105–113 eCollection 2016PubMedPubMedCentralGoogle Scholar